These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4208285)

  • 21. In vitro susceptibility of Listeria monocytogenes to some antibiotics and their combinations.
    Espaze EP; Roubeix YG; Le Berre JY; Courtieu AI
    Zentralbl Bakteriol Orig A; 1978 Jan; 240(1):76-85. PubMed ID: 416625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination.
    Jones RN; Barry AL
    J Clin Microbiol; 1987 Oct; 25(10):1920-5. PubMed ID: 3117843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
    Laxer RM; Mackay E; Marks MI
    Chemotherapy; 1975; 21(2):90-8. PubMed ID: 168040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro study of synergy of ampicillin with ceftriaxone against Listeria monocytogenes.
    Lepe JA; Rodríguez-Villodres A; Martín-Gutiérrez G; Luque R; Aznar J
    Rev Esp Quimioter; 2019 Oct; 32(5):465-468. PubMed ID: 31515975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci.
    Harwick HJ; Kalmanson GM; Guze LB
    Antimicrob Agents Chemother; 1973 Oct; 4(4):383-7. PubMed ID: 4791300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic susceptibility of clinical isolates of Listeria monocytogenes.
    Wiggins GL; Albritton WL; Feeley JC
    Antimicrob Agents Chemother; 1978 May; 13(5):854-60. PubMed ID: 96737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa.
    Meyer RD; Young LS; Armstrong D
    Appl Microbiol; 1971 Dec; 22(6):1147-51. PubMed ID: 5002900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative in vitro activity of 5 semi-synthetic penicillins against aerobic Gram-negative bacilli and enterococci (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):318-23. PubMed ID: 6460967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo studies of imipenem-cilastatin alone and in combination with gentamicin against Listeria monocytogenes.
    Kim KS
    Antimicrob Agents Chemother; 1986 Feb; 29(2):289-93. PubMed ID: 3087277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative activity of cefotaxime and selected beta-lactam antibiotics against Haemophilus influenzae and aerobic gram-negative bacilli.
    Dabernat HJ; Delmas C
    Rev Infect Dis; 1982; 4 Suppl():S401-5. PubMed ID: 6294790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.
    Girolami RL; Stamm JM
    Antimicrob Agents Chemother; 1980 Nov; 18(5):766-72. PubMed ID: 7447430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mezlocillin: a new acyl ureidopenicillin. Antimicrobial activity and combination effects with four aminoglycoside antibiotics.
    Schassan HH; Koperski K; Scherf H
    Chemotherapy; 1978; 24(3):134-42. PubMed ID: 95925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods.
    Parry MF; Neu HC
    Antimicrob Agents Chemother; 1976 Apr; 9(4):625-32. PubMed ID: 817662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the in vitro activity of ampicillin and moxifloxacin against Listeria monocytogenes at achievable concentrations in the central nervous system.
    Pupo I; Lepe JA; Smani Y; Aznar J
    J Med Microbiol; 2017 Jun; 66(6):713-720. PubMed ID: 28598305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PC-904, a novel broad-spectrum semisynthetic penicillin with marked antipseudomonal activity: microbiological evaluation.
    Noguchi H; Eda Y; Tobiki H; Nakagome T; Komatsu T
    Antimicrob Agents Chemother; 1976 Feb; 9(2):262-73. PubMed ID: 1046355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo activity of various antibiotics against Listeria monocytogenes type 4b.
    Hawkins AE; Bortolussi R; Issekutz AC
    Clin Invest Med; 1984; 7(4):335-41. PubMed ID: 6442656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro susceptibility of Listeria monocytogenes: comparison of the E test with the agar dilution test.
    Heger W; Dierich MP; Allerberger F
    Chemotherapy; 1997; 43(5):303-10. PubMed ID: 9309362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of the antibacterial activity of aminoglycoside antibiotics and their combinations with carbenicillin against Pseudomonas aeruginosa].
    Iakushkina IV; Shapovalova SP; Malkova IV
    Antibiotiki; 1982 Aug; 27(8):601-7. PubMed ID: 6812489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro synergy testing of nine antimicrobial combinations against Listeria monocytogenes.
    MacGowan AP; Holt HA; Reeves DS
    J Antimicrob Chemother; 1990 Apr; 25(4):561-6. PubMed ID: 2112538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.